ScholarWorks@Korea University College of Medicine: Kim, Eung Ju

Detailed Information

Kim, Eung Ju (김응주)

구로병원 (Department of Cardiology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Hypertension:10||coronary artery disease:10||Coronary artery spasm:9||hypertension:9||Acetylcholine:8||atrial fibrillation:8||Atrial fibrillation:7||coronary artery spasm:7||percutaneous coronary intervention:6||Drugeluting stent:6||Acute myocardial infarction:6||acetylcholine:6||Percutaneous coronary intervention:6||inflammation:5||blood pressure:5||Coronary artery disease:5||catheter ablation:5||carotid intimamedia thickness:4||Heart failure:4||Clinical outcomes:4||heart failure:4||myocardial infarction:4||pulse wave velocity:4||Blood pressure:4||Uric acid:4||computed tomography:4||coronary angiography:3||Cardiac rehabilitation:3||chronic total occlusion:3||Creactive protein:3||obesity:3||positronemission tomography:3||Acetylcholine provocation test:3||diabetes mellitus:3||diastolic function:3||Acute coronary syndrome:3||acute myocardial infarction:3||drugeluting stent:3||angina:3||endothelial dysfunction:3||angiotensin receptor blocker:3||exercise:3||Risk factors:3||Secondary prevention:3||Mortality:3||Hyperuricemia:3||left atrium:3||lipoprotein(a):3||Echocardiography:3||Slow release:2||Prevalence:2||restenosis:2||NTproBNP:2||dyslipidemia:2||risk factors:2||Primary clinics:2||Depression:2||Guideline:2||Computed tomography:2||left ventricular hypertrophy:2||left ventricular mass:2||Diabetes mellitus:2||singlepill combination:2||Paclitaxeleluting stents:2||Heart Failure:2||epidemiology:2||Spasm:2||cardiorespiratory fitness:2||Resistant hypertension:2||Atrial remodeling:2||Coronary angiography:2||Left atrium:2||medical therapy:2||arterial stiffness:2||statin:2||Heart failure with reduced ejection fraction:2||atherosclerosis:2||Atorvastatin:2||Epidemiology:2||Drug eluting stents:2||nicorandil:2||Clinical efficacy:2||Endovascular therapy:2||cardiovascular disease:2||losartan:2||Atherosclerosis:2||lowdensity lipoprotein cholesterol:2||mortality:2||metabolic syndrome:2||Drugeluting stents:2||Sirolimuseluting stents:2||coronary heart disease:2||positron emission tomography:2||Myocardial bridge:2||coronary spasm:2||Clinical practice guidelines:2||critical limb ischemia:2||Vasospastic angina:2||Myocardial infarction:2||psoas muscle:2||DES:2||Carvedilol:2||Percutaneous transluminal angioplasty:2||Statins:2||radial artery:2||Catheter ablation:2||Insulin resistance:2||carvedilol:2||outcomes:2||Fistula:1||Followup:1||Frail elderly:1||Function:1||Gastroesophageal reflux:1||Graft stent:1||HDL:1||Haematopoietic activity:1||Health surveys:1||Heart atria:1||Heart atria/abnormalities:1||Heart rate variability:1||Hemoglobin A1c:1||Hypertension Resistant to Conventional Therapy:1||Immediate release:1||Inflammation:1||Interarm blood pressure:1||Internet:1||Intravascular ultrasound:1||Irbesartan:1||Korea:1||L1 SMI:1||LVH:1||Lacidipine:1||Large coronary artery:1||Left atrial function:1||Left main coronary artery:1||Left ventricular mass:1||Linear ablation:1||Lipid profile:1||Liquid chromatographymass spectrometry:1||Liver S9 fraction:1||Longterm clinical outcome:1||Losartan:1||MACE:1||MDCT:1||Major adverse cardiac event:1||Major adverse cardiac events:1||Major adverse event:1||Major clinical outcomes:1||Mean platelet volume:1||Medication adherence:1||Metabolic equivalent:1||Metabolic syndrome:1||Metabolic variability:1||Metal jacket:1||Mild Cognitive Impairment:1||Mobile health:1||Multivessel disease:1||Myocardial Infarction:1||Myocardial infarction ；Interleukin 6；Pselectin.:1||Myocardial injury:1||Neutrophil/lymphocyte ratio:1||New onset diabetes mellitus:1||Newonset diabetes mellitus:1||Nicorandil:1||Nomogram:1||Noncardiac surgery:1||Obesity:1||Obstructive sleep apnea:1||Oculopharyngeal muscular dystrophy:1||Oxygen consumption:1||PTA:1||PWW:1||Percutaneous transluminal coronary angioplasty:1||Perindopril:1||Peripheral artery disease:1||Peripheral vascular disease:1||Phase IV:1||Positronemission tomography:1||Posterior wall:1||Psychiatric status rating scales:1||Pulse wave velocity:1||ROC curve:1||Radial artery:1||Receptor:1||Reproducibility:1||Right atrial mass.:1||Right coronary artery:1||Risk factor:1||Rosuvastatin:1||SCAD:1||SES:1||ST elevation myocardial infarction:1||ST segment:1||Sex:1||Sex Factors:1||Single coronary artery:1||Skeletal muscle mass:1||Sleep deprivation:1||Sleep disorders:1||Sleep quality:1||Smoking:1||Spontaneous dissection:1||StentBoost:1||Stroke:1||Telephone:1||Tissue Doppler imaging:1||Transesophageal incidental findings:1||Transfemoral intervention:1||Transradial intervention:1||Treatment:1||Triglyceride:1||Validation study:1||Valsartan:1||Variability:1||Vascular complications:1||Vascular endothelium:1||Vasoconstriction:1||Vasomotion type:1||Visceral adiposity:1||Visceral fat:1||ZES:1||Zotarolimuseluting stents:1||aPWV:1||adjunctive balloon:1||aging:1||air pollution:1||amlodipine:1||amputation:1||angiography:1||angiotensin:1||angiotensin converting enzyme inhibitor:1||angiotensinconverting enzyme inhibitor:1||antithrombotic therapy:1||aorta:1||aortic stiffness:1||arterial pulse wave velocity:1||arteriosclerosis/blood:1||atrial function:1||atrial function, left/physiology:1||augmentation index:1||bilateral coronary artery fistula:1||biological markers/blood:1||bisoprolol:1||blood glucose:1||blood pressure control:1||blood sugar control:1||body composition:1||body mass index:1||bone marrow:1||brachialankle pulse wave velocity:1||cardiac rehabilitation:1||cardiac volume:1||cardiomyopathies:1||cardiovascular events:1||celecoxib:1||central blood pressure:1||central hemodynamics:1||cerebral infarction:1||chlorthalidone:1||cholesterol, LDL/analysis/blood/classification/drug effects:1||cilostazol:1||clinical followup:1||clinical outcomes:1||collateral circulation:1||communication between two fistulas:1||computerised tomography:1||control:1||control/therapy:1||coronary:1||coronary artery disease/prevention &:1||coronary microvascular function:1||coronary vasospasm:1||cytokines:1||data crawling:1||data mining:1||dense lowdensity lipoprotein:1||diabetic:1||direct intraarterial measurement:1||disease progression:1||dissection:1||drug eluting stent:1||echocardiography:1||elderly:1||electrocardiography:1||electronic health record:1||endocardium:1||endothelial function:1||epicardial adipose tissue:1||epicardial fat:1||ethnic groups:1||exercise capacity:1||exfoliative dermatitis:1||extracellular fluid:1||fenofibrate:1||fibroelastosis:1||fimasartan:1||followup:1||global health:1||hand grip strength:1||handgrip:1||health status disparities:1||healthy volunteers:1||heart atria/pathology/ultrasonography:1||hyperlipidemia:1||hyperlipidemias/prevention &:1||hyperuricaemia:1||index of microvascular resistance:1||inflammatory:1||insulin resistance:1||intracoronary acetylcholine provocation test:1||large artery stiffness:1||left:1||left atrial function:1||left ventricle:1||left ventricular function:1||lipid profile:1||lipids:1||lipoproteins, LDL/blood/chemistry:1||machine learning:1||magnetic resonance imaging:1||major adverse cardiac events:1||mannose receptor:1||meloxicam:1||middle aged women:1||multidetector computed tomography:1||multivessel:1||multivessel coronary artery spasm:1||multivessel disease:1||natural language processing:1||newonset diabetes mellitus:1||nitrate:1||noncontact mapping:1||nonionic contrast medium (iodixanol):1||nonselective ssblockers:1||nonsteroidal antiinflammatory drugs:1||odds ratio:1||olmesartan:1||outcome:1||particle size:1||percutaneous coronary intervention/adverse effects/mortality:1||perindopril:1||peripartum period:1||peripheral arterial disease:1||peripheral transluminal angioplasty:1||platelets:1||prediabetes:1||predictive value of tests:1||pregnancy:1||prehypertension:1||preoperative care/methods:1||pulse pressure:1||pulse wave analysis:1||quality of life:1||randomized controlled trial:1||recanalization:1||recovery of function:1||recurrence:1||remodeling:1||reninangiotensin system:1||retrospective studies:1||revascularization:1||risk prediction:1||rosuvastatin:1||safety:1||sarcopenia:1||selective ss 1blockers:1||sentiment analysis:1||sex differences:1||sirolimuseluting stent:1||skeletal muscle:1||skeletal muscle index:1||sleep:1||sleep deprivation:1||small:1||smartphone app:1||social class:1||socioeconomic factors:1||spasm:1||spleen:1||statin responsiveness:1||stent fracture:1||stents:1||stroke:1||subacute stent thrombosis:1||superior mesenteric artery aneurysms:1||target organ damage:1||threedimensional multidetector CT:1||thrombolysis in myocardial infarction flow:1||thrombosis:1||tissue Doppler:1||tissue Doppler imaging:1||tomography, Xray computed/methods:1||transluminal attenuation gradient:1||treatment outcome:1||triglyceride:1||type 1:1||uric acid:1||urinary sodium:1||validation studies:1||variant angina:1||vasospasm:1||ventricular function:1||visceral artery aneurysms:1||visceral fat:1||복부비만:1||심근경색증；Interleukin6 ；Pselectin.:1||심방세동；심방기외수축；구조활성화 관계.:1||운동:1||젊은 연령의 심근경색증 환자에서 Homocysteine의 영향:1||중년기 여성:1||한국인의 관동맥질환에 띠른 혈중 지질 및 위험인자의 비교연구:1||혈압:1||(V)over doto(2max):1||혈청지질. 혈당:1||18FFDGPET/CT:1||24hour Holter study:1||6minute walk test:1||ABC transporters:1||AMI:1||Abdominal obesity:1||Ablation time:1||Access site:1||Acetylcholine dose:1||Achinduced coronary vasospasm:1||Ach: acetylcholine:1||Adipocytes:1||Adolescent:1||Alcohol:1||Amlodipine:1||Amygdalar activity:1||Aneurysm:1||Angina:1||Angina pectoris:1||Angina pectoris, variant:1||Angioplasty:1||Angiotensin:1||Angiotensin II:1||Angiotensin converting enzyme inhibitor:1||Angiotensin receptor blocker:1||Antilipemic agents/therapeutic use:1||Antiplatelet therapy:1||Aortic calcification:1||Aortic stiffness:1||Apneahypopnea index:1||Apolipoprotein AI:1||Arachidonic acid:1||Arterial inflammation:1||Arterial stiffness:1||Asian:1||Aspirin:1||Atrial fibrillation/physiopathology:1||Atrial fibrillation；Atrial premature complexes；Structureactivity relationship.:1||Atrial mass:1||Atrial septal aneurysm:1||Atrial septum:1||Automatic external biphasic defibrillator:1||Awareness:1||Btype natriuretic peptide:1||BMS:1||Baremetal stent:1||Blood glucose:1||Body image:1||Body size phenotype:1||Brain:1||CAS:1||CHA(2)DS(2)VASc score:1||CV events:1||Calcium channel blocker:1||Cardiac CT:1||Cardiac autonomic dysfunction:1||Cardiopulmonary coupling analysis:1||Cardiorespiratory Fitness:1||Cardiorespiratory fitness:1||Cardiovascular Disease:1||Cardiovascular diseases:1||Cardiovascular outcome:1||Chest pain:1||Cholesterol:1||Chronic heart failure:1||Chronic total occlusion:1||Cigarette smoking:1||Cilostazol:1||Circumflex coronary artery:1||Clinical followup:1||Clinical outcome:1||Clinical practice guideline:1||Cognitive Dysfunction:1||Combination:1||Complex fractionated atrial electrograms:1||Complications:1||Congenital:1||Cor pulmonale:1||Coronary anomaly:1||Coronary artery stenosis:1||Coronary calcification:1||Coronary disease:1||Coronary occlusion/therapy:1||Coronary rupture:1||Coronary vessels:1||Crista terminalis:1||Critical limb ischemia:1||Cryptogenic stroke:1||Cumulative exposure:1||DOCAsalt hypertension.:1||Death:1||Defibrillation:1||Diabetes:1||Diagnosis:1||Diastole:1||Diltiazem:1||Drug eluting stent:1||ECG:1||Eicosanoids:1||Elderly:1||Electrocardiogram:1||Endothelium:1||Epicardial adipose tissue:1||Epitestosterone:1||Essential hypertension:1||Exercise Capacity:1||Fibrillation detection algorithm:1||Fimasartan:1||

STATISTICS: Total View :10,887,523; Today View :13,335

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE